Astellas Pharma has submitted an NDA to Japan's Ministry of Health, Labour and Welfare seeking conditional approval of ACP.

The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...

During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a ...

MedPharm has appointed Bill Humphries as its new CEO, marking a significant step in the company's strategic growth.

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

On World Cancer Day, tackling barriers in equitable care requires not only policy action, but a shift in how cancer is ...

USC has received a $6m grant from the California Institute for Regenerative Medicine (CIRM) to advance a new gene therapy for ...

Immunotherapeutics have transformed cancer outcomes. It is crucial that response patterns seen with them are assessed ...

Vanda and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise imsidolimab to ...